<DOC>
	<DOCNO>NCT00860626</DOCNO>
	<brief_summary>For HBeAg ( + ) patient , interferon use 12 week . On 12th week treatment , If HBV DNA undetectable ( &lt; 1000 copies/ml ) , interferon continue alone one year . If HBV DNA still positive , nucleoside analogue add 3 month . After nucleoside analogue add 3 month , HBV DNA test . If negative , stop nucleoside analogue use interferon alone another 6 month longer . If HBV DNA still positive , change another nucleoside analogue add another nucleoside analogue .</brief_summary>
	<brief_title>Early Response Interferon Combined Short-Term Nucleoside Analogue Therapy HBeAg ( + ) Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>HBsAg posive 6 month HBeAg positive , HBeAb negative HBV DNA &gt; 1.0×E5 copies/ml ALT &gt; 80 u/L within 3 month pregnant woman conbination infection HCV , HAV , HEV conbination infection HIV contraindication interferon α</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>